Telaprevir Experience From Turkey

KÖMÜR S., KURTARAN B., İNAL A. S., PULLUKÇU H., ULU A., Kuscu F., ...More

HEPATITIS MONTHLY, vol.15, no.2, 2015 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 15 Issue: 2
  • Publication Date: 2015
  • Doi Number: 10.5812/hepatmon.25639
  • Journal Name: HEPATITIS MONTHLY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Çukurova University Affiliated: Yes

Abstract

Background: In patients with chronic hepatitis C, triple drug regimens containing a protease inhibitor, peginterferon and ribavirin were found to significantly increase sustained virologic response rates compared to dual drug regimen containing pegylated interferon and ribavirin, especially in genotype 1.